Bioavailability of Variably Aged MK-0974 Tablets (MK-0974-038)(COMPLETED)

• Status: Completed
• Trial end date: 2007-11-01
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the comparative bioavailability of three capsule formulations of MK-0974.

• Phase: Phase 1
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: Merck Sharp & Dohme Corp.

Criteria

Inclusion Criteria:

• Subject is in good health

• Subject is a nonsmoker

• Subject is willing to comply with the study restrictions

Exclusion Criteria:

• Subject has a history of stroke, chronic seizures, or major neurological disorder

• Subject has a history of cancer

• Subject is a nursing mother

• Subject has or has a history of any illness that might make participation in the study unsafe or confound the results of the study